Submit Deal

Submit Deal

Cover Image Michael Aberman

Michael Aberman

Interim Chief Business Officer at EXCISION BIOTHERAPEUTICS

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 43 M

Avg. Deal Size£ 43 M

Market Context

Sort

17 Feb 2021|United States|Pharmaceuticals

Target: EXCISION BIOTHERAPEUTICS

Bidder: ANZU PARTNERS

11 Service Providers

2 Target | 9 Bidder

22 Dealmakers

8 Target | 14 Bidder

£ 43 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite